Clinical trial NCT06787118
Status: Not yet recruitingPhase 3Latest change: Source: ClinicalTrials.gov
What's on this page?
Information in the record
Original title: Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer
- Record number
- NCT06787118
- Status
- Not yet recruiting
- Type and phase
- Clinical trial, phase 3
- Participants
- Target: 130
- Condition (as registered)
- Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, HR+ Breast Cancer, AI-related Musculoskeletal Pain
- Countries
- France
- Topic in the guide
- Cancer Pain, Arthritis and Osteoarthritis
Timeline
According to the ClinicalTrials.gov record. Future dates are the investigator’s estimates and may change.
- Start: December 2025
- End of data collection for primary results: May 2027 (expected)
- Trial completion: May 2027 (expected)
History
We check the record every day; here are the changes we have seen since we started tracking it, newest first.
- : Added to tracking. Status: Not yet recruiting.
Results
No results have been published yet. When they are, they will appear here. A trial being under way does not mean CBD works for this condition; only the results can show that.
All ongoing trials · Cancer Pain: ongoing trials · Arthritis and Osteoarthritis: ongoing trials · Thinking of taking part? Which specialist to see